Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
106.00    -3.00 (-2.75%)
Bid:
105.00
Ask:
107.00
Spread: 2.00 (1.905%)
Market Cap: £104.46m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

AGM Trading Update

19 May 2016 07:00

RNS Number : 6543Y
Eurocell plc
19 May 2016
 

19th May 2016

 

Eurocell plc

AGM Trading Update and Director Appointment

 

Eurocell plc ("Eurocell" or the "Company"), the leading sustainable B2B supplier of PVC building products with its own distribution network, today provides a trading update for the first 20 weeks of the financial year to 13th May 2016.

Eurocell has had a positive start to the year with Group revenues up 16.3% to £69.8 million. Both the Profiles and the Building Plastics divisions delivered improved revenues on last year, with like for like sales in the branch network ahead by 11.8%, although in a very competitive market. There were 7 new branches opened during the period and the Company is on track to deliver 15 new sites in the current year as a whole. Both of the recent acquisitions, S & S Plastics and Vista Panels are delivering to expectations.

The UK RMI market conditions remain stable, and benefited from relatively mild weather in January and February. We have seen some movement in resin prices through ethylene increases, this has had limited impact to date.

We are also pleased to announce the appointment of Michael Scott as Chief Financial Officer on 1st September 2016. Michael is currently Head of Corporate Finance at Drax Group plc. He has been with Drax since 2005, having previously held the positions of Head of Investor Relations and Group Financial Controller. Michael also served as Interim Group Finance Director between May and December 2015. Prior to joining Drax, he worked for MT International and Arthur Andersen, where he qualified as a Chartered Accountant.

The half year results will be announced on 23 August 2016.

 

Bob Lawson, Chairman of Eurocell, commented:

"Eurocell has had a positive start to the year. We are delighted with today's appointment of Michael as CFO. He will bring considerable relevant experience particularly given his recent finance and IR roles at Drax. Alongside Mark, who is already making a positive impact as CEO, we have the right management team to further develop Eurocell from the strong platform they inherit. Overall, the business is positioned well and I am confident about our prospects for the future."

 

There are no further disclosures to be made on the appointment of Michael Scott pursuant to 9.6.13 of the Listing Rules

 

Further Enquiries:

Ben Foster, Camilla Cunningham 020 3603 5221

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAPMFTMBMBBBF
Date   Source Headline
18th May 20264:00 pmRNSDirector/PDMR Shareholding
14th May 20261:49 pmRNSResult of AGM
14th May 20267:00 amRNSTrading Update
1st May 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSLeadership Update - CFO Appointment
15th Apr 20267:00 amRNSPublication of 2025 Annual Report & Notice of AGM
23rd Mar 202610:15 amRNSDirector/PDMR Shareholding
19th Mar 202610:30 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2025
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
17th Feb 20267:00 amRNSTransaction in Own Shares - Buyback Complete
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20261:00 pmRNSDirectorate changes
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSDirector/PDMR Shareholding
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSYear End Trading Update
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:00 pmRNSPurchase of Shares via Employee Benefit Trust
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.